Journal
BIOMATERIALS
Volume 32, Issue 23, Pages 5498-5504Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2011.04.018
Keywords
Cytokine; Molecular biology; Protein; Affinity; Bioactivity
Funding
- Ministry of Education, Culture, Sports, Science and Technology of Japan
- Japan Society for the Promotion of Science (JSPS)
- Ministry of Health, Labor and Welfare of Japan
- Japan Health Sciences Foundation
- Grants-in-Aid for Scientific Research [22790104, 22790180, 21390046] Funding Source: KAKEN
Ask authors/readers for more resources
Tumor necrosis factor-alpha (TNF) is one of the attractive targets for the development of anti-inflammatory and anti-tumor drugs, because it is an important mediator in the pathogenesis of several inflammatory diseases and tumor progression. Thus, there is an increasing need to understand the TNF receptor (TNFR1 and TNFR2) biology for the development of TNFR-selective drugs. Nonetheless, the role of TNFRs, especially that of TNFR2, remains poorly understood. Here, using a unique competitive panning, we optimized our phage display-based screening technique for isolating receptor-selective TNF mutants, and identified several TNFR2-specific TNF mutants with high TNFR2 affinity and full bioactivity via TNFR2. Among these mutants, the R2-7 clone revealed very high INFR2-selectivity (1.8 x 10(5) fold higher than that for the wild-type TNF), which is so far highest among the reported TNFR2-selective TNF mutants. Because of its high TNFR2-selectivity and full bioactivity, the TNF mutant R2-7 would not only help in elucidating the functional role of TNFR2 but would also help in understanding the structure-function relationship of TNF/TNFR2. In summary, our one-step competitive panning system is a simple, useful and effective technology for isolating receptor-selective mutant proteins. (C) 2011 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available